Risk regulation conference paper; the thalidomide apology; and unlawful welfare convictions
In late November, I presented a paper via video link to the Australasian Association of Bioethics and Heath Law (AABHL) on ‘risk-based regulation.’ The abstract for that paper was as follows: What risk? A critical analysis of risk-based regulation of therapeutic goods, from stem cell medicine to osseointegration devices Therapeutic goods (medicines, biologicals and devices) […]